DoJ Launching “Pharmaceutical Fraud Initiative” Ahead Of Medicare Rx
Executive Summary
The Department of Justice is launching a "pharmaceutical fraud initiative" to coordinate and increase investigative resources ahead of the Medicare drug benefit's implementation, DoJ Criminal Division Fraud Section Deputy Chief Karen Morrissette said
You may also be interested in...
Paxil Fraud Case May Spur Congressional, FDA Action – Schering Exec
Fallout from GlaxoSmithKline's handling of Paxil pediatric studies may lead to increased pressure by Congress or FDA for greater disclosure, Schering-Plough Senior VP-Global Compliance & Business Practices Brenton Saunders said
Paxil Fraud Case May Spur Congressional, FDA Action – Schering Exec
Fallout from GlaxoSmithKline's handling of Paxil pediatric studies may lead to increased pressure by Congress or FDA for greater disclosure, Schering-Plough Senior VP-Global Compliance & Business Practices Brenton Saunders said
Internet Pharmacy Regs Proposed By Senate Would Rely On Web Providers
The Senate leadership's drug importation bill proposes to police Internet pharmacies through regulations on Web service providers